Where it is
Palazzo dei Congressi (Convention Centre), Switzerland
Pin located with Geoapify · map data © OpenStreetMap contributors
Open in Google Maps ↗Everything theFasti holds on this meeting
- Organiser
- European Society for Medical Oncology (ESMO)
- Dates
- 8–10 March 2027
- Accreditation, in full
- ESMO-MORA: The ESMO Novel Cancer Therapies 2027 programme will be accredited with ESMO-MORA category 1 points.
- Registration
- Registration is now open; early until 13 Jan 2027, late until 10 Feb 2027, full from 11 Feb 2027
- Registration cost
- Early (until 13 Jan 2027): ESMO Member EUR 300.00 / Non-Member Academia EUR 380.00; full (from 11 Feb 2027) EUR 580.00 / EUR 720.00 (8.1% Swiss VAT included)
- Title in English
- ESMO Novel Cancer Therapies 2027
- Venue
- Palazzo dei Congressi (Convention Centre)
- City
- Lugano
- Country
- Switzerland
- Region
- Western Europe
- Specialty
- Oncology
- Subspecialty
- General oncology
- Also relevant to
- Clinical Pharmacology, Nursing & Allied Health
- Format
- In person
- Language
- English
- Date confidence
- Confirmed on the organiser’s own page
- Listing last checked
- 21 September 2026
CPD and CME
Nobody has counted the attendable hours for this meeting yet, and the organiser states no figure this site could use without guessing.
Read from the organiser’s own page on 21 September 2026 — confirm with the organiser before you rely on it.
theFasti referenceESMO-2027-005 Permanent. It stays with this meeting even if this page’s address changes, so it is safe to quote. ESMO is European Society for Medical Oncology (ESMO).
theFasti is a directory, not an organiser. Everything above was read from the organiser’s own page on the date shown, and conference dates and venues move — confirm with the organiser before you register or book. Something wrong? Tell us about this listing
Report this listing as misleading Goes privately to theFasti. Nothing you send appears on this page, and no count or badge is ever shown here — a report starts a check, it does not publish a verdict about anyone.